| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
by Nitric Oxide in Monocytes/Macrophages Down-Regulates p47phox and Attenuates the Respiratory Burst1
Institute of Cell Biology, University of Kaiserslautern, Kaiserslautern, Germany
NO appears as an important determinant in auto and
paracrine macrophage function. We hypothesized that NO switches
monocyte/macrophage function from a pro- to an anti-inflammatory
phenotype by activating anti-inflammatory properties of the
peroxisome proliferator-activated receptor (PPAR)
. NO-releasing
compounds (100 µM S-nitrosoglutathione or 50 µM
spermine-NONOate) as well as inducible NO synthase induction provoked
activation of PPAR. This was proven by EMSAs, with the notion that
supershift analysis pointed to the involvement of PPAR. PCR analysis
ruled out induction of PPAR mRNA as a result of NO supplementation.
Reporter assays, with a construct containing a triple PPAR response
element in front of a thymidine kinase minimal promoter driving the
luciferase gene, were positive in response to NO delivery. DNA binding
capacity as well as the transactivating capability of PPAR were
attenuated by addition of the antioxidant
N-acetyl-cysteine or in the presence of the NO scavenger
2-phenyl-4,4,5,6-tetramethyl-imidazoline-1-oxyl 3-oxide. Having
established that NO but not lipophilic cyclic GMP analogs activated
PPAR, we verified potential anti-inflammatory consequences. The
oxidative burst of macrophages, evoked by phorbol ester, was attenuated
in association with NO-elicited PPAR activation. A cause-effect
relationship was demonstrated when PPAR response element decoy
oligonucleotides, supplied in front of NO delivery, allowed to regain
an oxidative response. PPAR-mediated down-regulation of p47
phagocyte oxidase, a component of the NAD(P)H oxidase system, was
identified as one molecular mechanism causing inhibition of superoxide
radical formation. We conclude that NO participates in controlling the
pro- vs anti-inflammatory phenotype of macrophages by modulating
PPAR.
This article has been cited by other articles:
|
|
 |
|
  T. Sato, T. Shimosato, W. G. Alvord, and D. M. Klinman Suppressive Oligodeoxynucleotides Inhibit Silica-Induced Pulmonary Inflammation J. Immunol., June 1, 2008; 180(11): 7648 - 7654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Beyer, G. L. Baumbach, C. M. Halabi, M. L. Modrick, C. M. Lynch, T. D. Gerhold, S. M. Ghoneim, W. J. de Lange, H. L. Keen, Y.-S. Tsai, et al. Interference With PPAR{gamma} Signaling Causes Cerebral Vascular Dysfunction, Hypertrophy, and Remodeling Hypertension, April 1, 2008; 51(4): 867 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ceolotto, A. Gallo, I. Papparella, L. Franco, E. Murphy, E. Iori, E. Pagnin, G. P. Fadini, M. Albiero, A. Semplicini, et al. Rosiglitazone Reduces Glucose-Induced Oxidative Stress Mediated by NAD(P)H Oxidase via AMPK-Dependent Mechanism Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2627 - 2633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dhakshinamoorthy, S. R. Sridharan, L. Li, P. Y. Ng, L. M. Boxer, and A. G. Porter Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability Nucleic Acids Res., August 15, 2007; (2007) gkm594v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ptasinska, S. Wang, J. Zhang, R. A. Wesley, and R. L. Danner Nitric oxide activation of peroxisome proliferator-activated receptor gamma through a p38 MAPK signaling pathway FASEB J, March 1, 2007; 21(3): 950 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. von Knethen, M. Soller, N. Tzieply, A. Weigert, A. M. Johann, C. Jennewein, R. Kohl, and B. Brune PPAR{gamma}1 attenuates cytosol to membrane translocation of PKC{alpha} to desensitize monocytes/macrophages J. Cell Biol., February 26, 2007; 176(5): 681 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Klotz, I. Dani, F. Edenhofer, L. Nolden, B. Evert, B. Paul, W. Kolanus, T. Klockgether, P. Knolle, and L. Diehl Peroxisome Proliferator-Activated Receptor {gamma} Control of Dendritic Cell Function Contributes to Development of CD4+ T Cell Anergy J. Immunol., February 15, 2007; 178(4): 2122 - 2131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Motiwala, H. K. Janagama, M. L. Paustian, X. Zhu, J. P. Bannantine, V. Kapur, and S. Sreevatsan Comparative Transcriptional Analysis of Human Macrophages Exposed to Animal and Human Isolates of Mycobacterium avium Subspecies paratuberculosis with Diverse Genotypes. Infect. Immun., November 1, 2006; 74(11): 6046 - 6056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-H. Liu, J. Qu, and X. Shen Thioredoxin-mediated Negative Autoregulation of Peroxisome Proliferator-activated Receptor {alpha} Transcriptional Activity Mol. Biol. Cell, April 1, 2006; 17(4): 1822 - 1833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Soller, A. Tautenhahn, B. Brune, K. Zacharowski, S. John, H. Link, and A. von Knethen Peroxisome proliferator-activated receptor {gamma} contributes to T lymphocyte apoptosis during sepsis J. Leukoc. Biol., January 1, 2006; 79(1): 235 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Klotz, M. Schmidt, T. Giese, M. Sastre, P. Knolle, T. Klockgether, and M. T. Heneka Proinflammatory Stimulation and Pioglitazone Treatment Regulate Peroxisome Proliferator-Activated Receptor {gamma} Levels in Peripheral Blood Mononuclear Cells from Healthy Controls and Multiple Sclerosis Patients J. Immunol., October 15, 2005; 175(8): 4948 - 4955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Schopfer, Y. Lin, P. R. S. Baker, T. Cui, M. Garcia-Barrio, J. Zhang, K. Chen, Y. E. Chen, and B. A. Freeman Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor {gamma} ligand PNAS, February 15, 2005; 102(7): 2340 - 2345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Teissier, A. Nohara, G. Chinetti, R. Paumelle, B. Cariou, J.-C. Fruchart, R. P. Brandes, A. Shah, and B. Staels Peroxisome Proliferator-Activated Receptor {alpha} Induces NADPH Oxidase Activity in Macrophages, Leading to the Generation of LDL with PPAR-{alpha} Activation Properties Circ. Res., December 10, 2004; 95(12): 1174 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ma, X. Cui, S. Wang, J. Zhang, E. V. Nishanian, W. Wang, R. A. Wesley, and R. L. Danner Nitric oxide post-transcriptionally up-regulates LPS-induced IL-8 expression through p38 MAPK activation J. Leukoc. Biol., July 1, 2004; 76(1): 278 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Reddy, V. G. Keshamouni, S. H. Jaigirdar, X. Zeng, T. Leff, V. J. Thannickal, and T. J. Standiford Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-{gamma} ligands Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L613 - L619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Dobrian, S. D. Schriver, A. A. Khraibi, and R. L. Prewitt Pioglitazone Prevents Hypertension and Reduces Oxidative Stress in Diet-Induced Obesity Hypertension, January 1, 2004; 43(1): 48 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Y. LIM, J.-H. JANG, and Y.-J. SURH Induction of Cyclooxygenase-2 and Peroxisome Proliferator-Activated Receptor-{gamma} during Nitric Oxide-Induced Apoptotic PC12 Cell Death Ann. N.Y. Acad. Sci., December 1, 2003; 1010(1): 648 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. B. Schini-Kerth Homocysteine, a Proinflammatory and Proatherosclerotic Factor: Role of Intracellular Reactive Oxygen Species Circ. Res., August 22, 2003; 93(4): 271 - 273. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, S. Wang, R. A. Wesley, and R. L. Danner Adjacent Sequence Controls the Response Polarity of Nitric Oxide-sensitive Sp Factor Binding Sites J. Biol. Chem., August 1, 2003; 278(31): 29192 - 29200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tautenhahn, B. Brune, and A. von Knethen Activation-induced PPAR{gamma} expression sensitizes primary human T cells toward apoptosis J. Leukoc. Biol., May 1, 2003; 73(5): 665 - 672. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
